← Evidence map

ReviewCancer drug resistance (Alhambra, Calif.)2026

Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?

Wolfram C M Dempke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42729980